Connection
Maryam Asgari to Drug Approval
This is a "connection" page, showing publications Maryam Asgari has written about Drug Approval.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.605 |
|
|
|
-
Karas L, Lu CY, Agrawal PB, Asgari MM. The impact of the Orphan Drug Act on Food and Drug Administration-approved therapies for rare skin diseases and skin-related cancers. J Am Acad Dermatol. 2019 09; 81(3):867-877.
Score: 0.571
-
Albrecht J, Adamson AS, Barbieri JS, Bennett DD, Kiracofe EA, Kourosh AS, Leslie KS, Merola JF, Nguyen J, Siegfried E, Strickland N, Olbricht S, Asgari MM. Lack of a US Food and Drug Administration indication should not limit access to appropriate treatment. J Am Acad Dermatol. 2019 02; 80(2):577-578.
Score: 0.034